In this study, we found that SteelyA was responsible for the production of MPBD, a differentiation-inducing factor identified in the material released by the dmtA mutant and MPBD induced spore maturation. Extracellular cAMP is essential for prespore differentiation, GSK126 clinical trial but is not sufficient to induce the formation

of mature spores (Kay, 1982; Schaap & van Driel, 1985). Several (pre)spore-inducing factors have been reported so far (Oohata, 1995; Anjard et al., 1997, 1998; Oohata et al., 1997; Serafimidis & Kay, 2005; Saito et al., 2006) Two active spore-inducing factors were detected in a conditioned medium, one of which was called the psi factor (Oohata et al., 1997). In addition, the peptides SDF-1 and SDF-2 promote the terminal differentiation of spores (Anjard et al., 1998). The present results indicated that MPBD also regulated the terminal differentiation of spores. How these factors regulated spore differentiation and interacted with each other constitutes this website the next step of our research. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to T.S. (No. 20510196). T.B.N. is grateful for the Sophia type III scholarship. “
“Papiliocin is a 37-residue peptide isolated from the swallowtail butterfly Papilio xuthus. In this study, the antifungal effects and the mechanism

of actions of papiliocin were investigated. First of all, papiliocin was shown to exert fungicidal activity. To understand the antifungal mechanism(s), propidium iodide influx into Candida albicans cells, induced by papiliocin, was examined. The result indicated that papiliocin perturbed and disrupted the fungal plasma membrane. Furthermore, calcein leakage from large unilamellar vesicles and rhodamine leakage from giant unilamellar vesicles further confirmed and visualized the membrane-disruptive action of papiliocin in the fungal model membrane,

respectively. In summary, the present study suggests that papiliocin exerts its antifungal activity by a membrane-active mechanism and that this peptide can be developed into novel potent antifungal agents. Over Montelukast Sodium the past decade, treatment-resistant fungal strains, such as azole-resistant Candida spp., as well as both invasive and pathogenic molds, have emerged. Antifungal resistance is a broad concept, demonstrating the failure of antifungal therapy in treating fungal diseases in humans. Especially, the clinical resistance of fungi is frequently seen in patients with persistent, profound immune defects, or infected prosthetic materials, such as central venous catheters (Groll et al., 1998). Therefore, the increasing resistance of fungi to available antibiotics is a major concern worldwide, leading to extensive efforts to develop novel antibiotics. One promising drug model is the host-defense cationic antimicrobial peptides (AMPs) (Makovitzki et al., 2006).

Data from Africa showed an incidence of stage IV CKD of 7% in untreated patients after initiating antiretroviral therapy (using the

CG equation) [18] while the UK CHIC study reported a prevalence of stage V CKD of 0.31% (using the MDRD equations) [19]. To date, studies in HIV infection have used an extremely wide range of endpoints and methodologies. These include, but are not limited to, an eGFR<90 [1,20], <60 [17,20–27], <30 [18] or <15 mL/min/1.73 m2 [19], the rate of change in eGFR [18,21,24,28–32], a 20 [1], 25 [29] or 50% decline in eGFR [29], a 25% decrease in eGFR for those with an eGFR<60 mL/min/1.73 m2 [17,27],

a decline in eGFR of >3 mL/min/1.73 m2 per year [32], the rate of change in serum creatinine [33], and a 25% increase in [34] or doubling of serum creatinine [35]. Some studies check details have been cross-sectional [1,25], and some have used cystatin C to estimate eGFR rather than serum creatinine [32]. In some cases, although the 5-FU research buy study reports using the recommended classification system [13], CKD, however defined, is either not based on consecutive (i.e. confirmed values) measured at least 3 months apart or it is not clear whether or not this is the case [22,23,36,37]. Research into renal disease in HIV-infected persons is an expanding area and a welcome development for improving our understanding in this clinical area. Although there

is currently no consensus regarding which Fossariinae endpoint should be focused on, studies that focus on less advanced CKD, such as that by Tordato et al. [1], need to be interpreted with caution in light of the issues raised above and as the clinical relevance of such findings is not immediately clear. Risk factors for the development of less advanced CKD and outcomes in patients with small decreases in eGFR are likely to be different from those seen in patients with more advanced CKD, as are the likely interventions and management of these patients. As the field progresses, it will be useful to keep in mind the limitations of the available tools, for studies to consider a variety of sensitivity analyses using different endpoints or equations, and finally to work towards developing a common, useful, and clinically relevant endpoint. Such a common endpoint would help with identifying common risk factors and how these risk factors differ in different populations, facilitate appropriate interventions and enable changes over time or between patient populations to be monitored more easily.

parahaemolyticus possesses a full set of the exsACDE regulatory system, which is similar to that of P. aeruginosa and which regulates T3SS1-related gene expression. H-NS is a major component of the bacterial nucleoid and plays a crucial role in global gene regulation in enteric bacteria (Varshavsky et al., 1977; Hulton et al., 1990). H-NS affects the expression of many unrelated genes and several virulence genes in Salmonella DZNeP molecular weight enterica serovar Typhimurium, Shigella sp. and Vibrio cholerae (Maurelli & Sansonetti, 1988; Hulton et al., 1990; Tobe et al., 1993; Harrison et al., 1994; O’Byrne & Dorman, 1994;

Nye et al., 2000). Therefore, we examined the possibility that T3SS1 genes are part of the H-NS regulon. As shown in Fig. 3a, the production of VscC1 and VepA proteins in a Δhns strain was considerably increased in both the bacterial pellet and the supernatant compared with that of the WT. A ΔhnsΔexsA mutant strain did not exhibit

increased production of these proteins (Fig. 3b), suggesting that exsA is necessary for overproduction of T3SS1-related proteins via hns gene deletion. We next examined the possibility that H-NS represses exsA expression using an exsA–lacZ transcriptional fusion reporter (Fig. 3c). Transcription of exsA–lacZ was dramatically increased in the hns deletion strain compared with that in the WT. The increase in exsA–lacZ transcription in the hns deletion strain was suppressed by Staurosporine mouse in trans complementation with the Ixazomib supplier hns gene. These results

indicate that H-NS represses T3SS1-related gene expression by suppressing exsA gene expression. In summary, we identified VP1701 and VP1702 of V. parahaemolyticus as functional orthologues of P. aeruginosa ExsC and ExsE, respectively. As VP1701 has sequence similarity with its counterpart, it was not difficult to predict its function. Indeed, the production of T3SS1-related proteins was repressed in a Δvp1701 mutant and derepressed by complementation of the vp1701 gene (Fig. 1b and c). Unlike ExsA (VP1699), ExsD (VP1698) and ExsC (VP1701), sequence annotation of the T3SS1 region on the genome of V. parahaemolyticus did not reveal any CDSs predicted to encode the homologue of P. aeruginosa ExsE. However, we found that one hypothetical CDS (VP1702) was encoded next to the vp1701 (exsC) gene. Deletion of the vp1702 gene deregulated the production of T3SS1-related proteins. Furthermore, VP1702 itself was a substrate for the T3SS1 secretion system. These properties of VP1702 of V. parahaemolyticus conform with those of its counterpart in P. aeruginosa. In P. aeruginosa, the coupling of transcription to secretion is mediated by three interacting proteins (ExsC, ExsE and ExsD) that regulate ExsA transcription activity (Yahr & Wolfgang, 2006). Although it is still unknown whether ExsC, ExsE and ExsD of V.

Two kinds of complementation plasmids, pMA5-purL and pUC18-purL, were constructed for this purpose. The difference between the plasmids was that pMA5-purL is a multicopy shuttle expression vector and pUC18-purL is the suicide vector that can only be inserted between purQ and purF of M1. pMA5-purL and pUC18-purL were transformed into the M1 mutant, respectively, and transformants

confirmed by PCR and restriction enzyme digestion. The resulting M1-1 and M1-2 transformants were then separately tested for nematicidal activity. The mortality rates of M. javanica juveniles were 100% after a 12-h incubation in culture filtrates collected from either strain M1-1 or M1-2 (Fig. 2a). These rates were similar to those observed for the OKB105 wild-type strain, suggesting the purL gene of B. subtilis played a key role in Selleck Omipalisib mediating nematicidal activity. M1 was also chemically complemented, i.e. supernatants of M1 supplemented with adenine (12 μg mL−1) and thiamine (0.8 μg mL−1), or with AICA-riboside (4 mM) also resulted in 100% mortality of M. javanica juveniles at 12 h (Fig. 2b). In addition, to confirm whether the presence of the nematicidal

substances related to the purine biosynthesis, sulfamethoxazole or azaserine, which could interfere with the purine synthesis (Maegawa et al., 2002), was supplemented in Landy medium, respectively. Addition of sulfamethoxazole (250 μM) or azaserine (550 μM) in medium ERK inhibitors caused the nematicidal activity loss of OKB105 at 72 h. Landy culture medium alone supplemented with adenine and thiamine, with AICA-riboside, with sulfamethoxazole, or with azaserine had no effect on M. javanica viability at 72 h. Numerous studies have reported that bacterial culture filtrates possess nematicidal activity in vitro (Neipp & Becker, 1999; Tian & Riggs, 2000; Ali et al., 2002; Siddiqui & Shaukat, 2003; El-Nagdi & Youssef, 2004; Huang et al., 2005; Mendoza et al., 2008). Data presented in this report indicated that the bacterial

strains tested (OKB105, 69, B3, FZB42) had potential biological control activity against plant-parasitic nematodes. The purpose of this study was to identify B. subtilis nematicidal properties; strain OKB105 supernatants were shown to possess nematicidal activity against M. incognita, Meloidogyne arenaria and Meloidogyne hapla, similar to the activity observed against M. javanica, but had no effect on Rhabditis spp. at 72 h (data O-methylated flavonoid not shown). Several extracellular enzymes have been reported to show activity against plant-parasitic nematodes (Huang et al., 2005; Siddiqui et al., 2005; Niu et al., 2006; Tian et al., 2006). For example, 2,4-DAPG produced by P. fluorescens was used to control cyst and root-knot nematode juveniles (Cronin et al., 1997; Siddiqui & Shaukat, 2003). Oka et al. (1993) reported that ammonia and nitrite (toxic to second-stage M. javanica juveniles) could be identified from Bacillus cereus culture supernatants. Although a large number of studies have reported that B.

2 per 100 000) with AIDS, as of 1 January 2012 [1]. Timely initiation of HIV care and treatment

improves quality of life, stops HIV progression and prevents AIDS-related death. However, late enrolment of PLWH in HIV care at AIDS Centers is a significant challenge in Ukraine. One-third of people who tested HIV positive in Ukraine have not been seen for HIV care at specialized AIDS Centers [1]. Similarly, among those newly diagnosed with HIV infection, the proportion of people presenting for HIV care at the third or fourth clinical stage of HIV infection grew from 32.5% in 2009 to 40.0% in 2011 [2]. We aimed to explore the characteristics of patients enrolled in HIV medical care at the Regional AIDS Center in Odessa Region, Ukraine from 1995 to 2010, focussing on the association of a history of injecting drug use (IDU) and delayed enrolment in HIV care. Ku-0059436 solubility dmso A retrospective clinical medical Selleck Copanlisib record review was conducted for all patients registered for HIV care at the Odessa Regional AIDS

Center in Odessa, Ukraine, from 1 January 1995 to 31 December 2010. AIDS Centers provide care and treatment to all patients presenting with HIV infection and entering the HIV care system in Ukraine. Data on reported routes of HIV acquisition, demographic characteristics and other personal information were collected by the AIDS Center clinical staff during initial visits for the purposes of clinical care. The retrospective cohort of PLWH (aged ≥ 15 years) was stratified into two groups, depending on the reported route of HIV transmission. The main outcome of interest was elapsed time (days) between the dates of HIV diagnosis the and enrolment in HIV care. The nonparametric Mann−Whitney U-test was used to compare the groups. The cohort consisted of

15 434 HIV-positive individuals, aged ≥ 15 years, who enrolled in HIV care in Odessa Region between 1995 and 2010, including 8097 people who reported IDU as the route of HIV transmission [people who inject drugs (PWID)], and 7337 persons who reported sexual HIV transmission. Of the cohort, 58.8% (n = 9079) were male and 81.8% (n = 12 631) were urban residents, and the mean age was 31.7 years. The mean time between an HIV-positive test result and enrolment in HIV care (‘mean delay’, in days) among PWID in Odessa Region increased steadily from 1995 to 2010. People infected with HIV via IDU showed a significantly longer delay in enrolment compared with the group infected via sexual transmission. This was true on average for the 1995–2010 period (687 days versus 376 days, respectively), and in the year 2010 (1140 days versus 336 days, respectively) (Table 1). During the period analysed, the mean delay in enrolment in care among PWID increased for both men and women; the mean age of PWID at the time of enrolment in care also showed a gradual increase.

Anti-HBs antibody GMCs at year 4 were 42.3, 23.6, and 13.7 mIU/mL in the three groups, respectively. One month after the additional dose of hepatitis A-containing vaccine, ≥99.4% of subjects in all

the groups were seropositive VX-809 cell line for anti-HAV antibodies. Anti-HAV response rates were 98.2% in the HAB group, 97.6% in the ENG + HAV group, and 99.4% in the HBVX + VAQ group. One month after the additional dose of hepatitis B-containing vaccine, 95.2% of subjects in the HAB group had antibody concentrations ≥10 mIU/mL compared with 90.5 and 85.3% in the ENG + HAV and HBVX + VAQ groups (p = 0.1367 and p = 0.0026, respectively) (Figure 1B). Corresponding anti-HBs GMCs were 7233.7, 1242.5, and 1075.1 mIU/mL. Overall anti-HBs response rates were 93.4% in the HAB group, 88.1% in the ENG + HAV group, and 83.4% in the HBVX + VAQ group (p = 0.1305 and p = 0.0054, respectively). In subjects with anti-HBs antibody Proteasome inhibitor concentration <3.3 mIU/mL prior to administration of the additional vaccine dose, 82.1, 82.0, and 72.6% achieved an anti-HBs concentration ≥10 mIU/mL post-vaccination. In the three groups, virtually all seronegative subjects who failed to respond to the additional dose and reach the cut-off of 10 mIU/mL were already nonresponders, or very low

responders, to primary vaccination. Exploratory subgroup analyses showed hepatitis A and B seropositivity rates at year 4 to be slightly lower in subjects aged ≥61 years, with a BMI ≥30 kg/m2, receiving concomitant medication or with a current concomitant medical condition. No consistent effects of any of these factors on response to the additional vaccine dose(s) were observed (data not shown). We assessed persistence of immune response to a combined hepatitis A/B vaccine in adults aged >40 years. The study population can be considered representative of the general

population in this age group, with a high proportion of subjects being overweight, having underlying GBA3 medical conditions, or receiving concomitant medication. The differences in immune response between the combined hepatitis A/B vaccine and monovalent vaccines previously observed after primary vaccination6 were found to be maintained over time. As described in another follow-up study of this combined hepatitis A/B vaccine in this population,7 anti-HAV seropositivity rates remained high in all groups over the 4 years of follow-up. At year 4, anti-HBs rate ≥10 mIU/mL and anti-HBs GMCs were highest in subjects who received the combined vaccine, although these were lower than have been reported in younger adults 10 years after administration of this vaccine.8 The lower anti-HBs antibody response rates observed in the HBVX + VAQ group at all time-points may be due to the reduced HBsAg content and adjuvant composition of the hepatitis B vaccine in this group.

Intrathecal administration of the α2-adrenergic receptor antagonist yohimbine or the serotonergic receptor antagonist methysergide significantly

attenuated the LRN electrical stimulation-induced inhibition of the electromyogram responses. However, intrathecal application of the opioid receptor antagonist naloxone had no effect on the LRN electrical stimulation-induced inhibition. These results Sirolimus concentration suggest that the LRN–DLF–spinal cord pathway is involved in descending inhibition of the CSR, and spinal α2-adrenergic and serotonergic receptors participate in this descending inhibition. “
“Changes in synaptic efficacy and morphology are considered as the downstream mechanisms of consolidation of memories and other adaptive behaviors. In the last decade, neurotrophin-3 SAHA HDAC (NT-3) has emerged as one potent mediator of synaptic plasticity. In the adult brain, expression of NT-3 is largely confined to the hippocampal dentate gyrus (DG). Our previous studies show that application of high-frequency stimulation (HFS) sufficient to elicit long-term potentiation (LTP) at the DG-CA3

pathway as well as acute intrahippocampal microinfusion of brain-derived neurotrophin factor produce mossy fiber (MF) structural reorganization. Here, we show that intrahippocampal microinfusion of NT-3 induces a long-lasting potentiation of synaptic efficacy in the DG-CA3 projection accompanied by an MF structural reorganization of adult rats in vivo. It is considered that the capacity of synapses to express plastic changes is itself subject Buspirone HCl to variation depending on previous experience; taking into consideration the effects of NT-3 on MF synaptic plasticity, we thus used intrahippocampal microinfusion of NT-3

to analyse its effects on functional and structural plasticity induced by subsequent MF-HFS sufficient to induce LTP in adult rats, in vivo. Our results show that NT-3 modifies the ability of the MF pathway to present subsequent LTP by HFS, and modifies the structural reorganization pattern. The modifications in synaptic efficacy and morphology elicited by NT-3 at the MF-CA3 pathway were blocked by the presence of a Trk receptor inhibitor (K252a). These findings support the idea that NT-3 actions modify subsequent synaptic plasticity, a homeostatic mechanism thought to be essential for maintaining synapses in the adult mammalian brain. “
“Aerobic exercise may represent a useful intervention for drug abuse in predisposed individuals. Exercise increases plasticity in the brain that could be used to reverse learned drug associations. Previous studies have reported that exposing mice to a complex environment including running wheels after drug conditioning abolishes conditioned place preference (CPP) for cocaine, whereas running can enhance CPP when administered before conditioning.

Protein digestion was observed by a clear zone surrounding the holes.

To determine swimming motility, 0.3% agar with 1% tryptone and 0.25% NaCl were used (Sperandio et al., 2002). BM2 swarming medium (62 mM potassium phosphate buffer at pH 7, 2 mM MgSO4, 10 μM FeSO4, 0.4% glucose, RO4929097 nmr 0.1% casamino acids and 0.5% agar) was used for swarming motility (Overhage et al., 2007) and LB with 1.0% agar for twitching motility (Overhage et al., 2007). Briefly, the P. aeruginosa strain was grown from diluted overnight cultures to a turbidity of 1.0 at 600 nm. Each experiment was performed using at least two independent cultures. Overnight cultures of P. aeruginosa PAO1 were diluted 1 : 100 and grown to a turbidity http://www.selleckchem.com/products/PLX-4032.html of 1.0 at 600 nm with 1 mM indole, 1 mM 7-hydroxyindole, 1 mM 7FI or DMSO (0.1%, v/v) as a negative control. Antibiotics (0.06 mg mL−1 gentamicin, 10 mg mL−1 kanamycin and 0.8 mg mL−1 tetracycline) in the final concentration were mixed with cells and incubated

for 60 min without shaking. The cells that survived in the presence of antibiotics were enumerated on LB agar plates. Two independent cultures were used for each strain. Thirty-one commercially available indole derivatives (15 natural and 16 synthetic indole compounds) were screened for their ability to inhibit the biofilm formation and hemolysis of P. aeruginosa PAO1. The screening demonstrated various abilities to control the biofilm formation and hemolysis of P. aeruginosa, as some indole compounds, e.g. 3,3′-dimethyleneindole, increased and some indole compounds decreased biofilm formation (Table 1). Among the indole compounds tested, 7FI was the most effective at reducing both the biofilm formation and hemolytic activity of P. aeruginosa (Table 1). Specifically, the addition of 7FI (1 mM) decreased biofilm Rapamycin mw formation fourfold and hemolytic activity 14-fold. As the fluoride at carbon position 7 of

indole caused the most significant results, more fluoroindole compounds [4-fluoroindole (4FI), 5-fluoroindole (5FI), 6-fluoroindole (6FI), 5-fluorooxindole, 8-fluoroquinoline] and indole derivatives with different functional groups at carbon position 7 were investigated. 4FI, 5FI and 6FI reduced hemolytic activity 10-fold but their antibiofilm activity was less potent than 7FI. As the most potent antibiofilm and antihemolysis compound, 7FI was focused on. 7FI clearly and dose-dependently inhibited the biofilm formation and hemolytic activity of P. aeruginosa (Fig. 1a,b). Although three fluoroindoles at 1 mM slightly delayed the cell growth of P. aeruginosa, growth recommenced after 24 h (Fig. 1c). The overall data (Table 1, Fig. 1) indicated that the antibiofilm and antihemolysis activity of fluoroindoles at 1 mM was not due to its antimicrobial activity. As P.

Please note: Wiley-Blackwell is not responsible for the content or functionality of any supporting materials supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for the article. “
“Streptococcus pyogenes causes a broad spectrum of acute infections and is the bacterium most frequently GDC-0199 in vitro isolated from patients with pharyngitis. A number of antibiotics including penicillin have been shown to be effective, although antibiotic treatment

failure in cases of streptococcal pharyngitis have been reported. Herein, we aimed to elucidate the features of recurrent strains using clinical isolates. Ninety-three S. pyogenes organisms were obtained from Japanese patients with recurrent pharyngitis. Following genetic characterization, M-type isolates from patients with recurrent pharyngitis differed from those obtained at initial onset in 11 of 49 episodes, and pulsed field gel electrophoresis analysis showed different patterns in those cases. Additionally, spe genotyping revealed click here that the Spe type of the strains obtained at secondary onset corresponded with those from the initial onset in 22 cases. Furthermore, antibiotic

susceptibility testing revealed that more than half of the strains were resistant to macrolides and lincosamides, which was a much greater ratio as compared with the strains obtained from initial onsets in previous studies. Our results suggest that recurrence and reinfection are often confused during the diagnosis of repetitive and persistent streptococcal pharyngitis. Moreover, the present S. pyogenes

organisms were less susceptible to antibiotics, which raises caution about their appropriate use in clinical practice. Streptococcus pyogenes, also known as Group A Streptococcus, is a common human pathogen that causes a broad spectrum of acute infectious diseases ranging from noninvasive diseases, such as Tacrolimus (FK506) pharyngitis, skin infections, and acute rheumatic fever, to more life-threatening invasive infections, including myositis, necrotizing fasciitis, sepsis, and streptococcal toxic shock syndrome (Cunningham, 2000). Streptococcal pharyngitis is frequently observed in infants and adolescents, and most bacterial pharyngitis cases are caused by S. pyogenes. A variety of antibiotics have been suggested to be effective for treating streptococcal pharyngitis, including penicillins, cephalosporins, macrolides, and lincosamides. Currently, penicillin remains the treatment of choice, because of its proven efficacy and safety, narrow spectrum, and low cost (Dajani et al., 1995; Bisno et al., 2002). However, antibiotic treatment failure has been reported in clinical cases of streptococcal pharyngitis (Macris et al., 1998; Kuhn et al., 2001). Several theories have been proposed to account for this phenomenon, including the coexistence of β-lactamase-producing bacteria (Brook, 1994) and internalization of S.

This study aimed to explore the potential implication in initial adherence or host specificity of the specific sequences. In the SSH library, we obtained 115 unique fragments that were specific to the bovine strain. These fragments include sequences with homology to genes or pathogenicity islands (PAIs) present only in other specific E. coli pathotypes

(e.g. VTEC) or other species (e.g. Klebsiella, Nitromonas), which are not known to be present in EHEC strains of serogroup O26. This heterogeneity supports the hypothesis of a horizontal acquisition of genomic regions from other pathogenic bacteria (Brzuszkiewicz et al., 2009; Juhas et al., 2009; Kelly et al., 2009). Moreover, it reflects the genomic plasticity of EHEC and/or E. coli strains. This finding supports the hypothesis Alpelisib concentration of Mokady et al. (2005), suggesting that this variation in the genome contents of E. coli could indicate that its evolutionary strategy tends to create a mixed assortment

of virulence factors coming from various pathogenic strains. This combination leads to a unique set of such factors, which helps the bacteria to better survive. The PAI ICL3 locus, first described by Shen et al. (2004) in the VTEC O113:H21 E. coli CL3, was found in 11.3% of the tested EHEC and EPEC strains of serogroup O26. These results are surprising when compared to those obtained by Girardeau et al. Forskolin solubility dmso (2009), suggesting that PAI ICL3 is unique to LEE-negative VTEC strains and that this locus thus provides a new marker for such strains. We have reported here that the locus could also be present in eae-positive strains belonging to a major serogroup involved in human diseases. Girardeau et al. (2009) have suggested that PAI ICL3 used to be present in most E. coli pathotypes but that many of these pathotypes have undergone extensive deletions [probably

via homologous recombination between insertion sequences (IS) elements, which removed almost the entire locus]. We can assume that our positive strains were not deleted for this locus. Another possible explanation is that these strains have recently Pyruvate dehydrogenase lipoamide kinase isozyme 1 acquired the PAI ICL3 locus via horizontal transfer, which hypothesis is supported by the fact that the PAI ICL3-positive strains are not closely related. Concerning host specificity, only one sequence appears to be statistically specific to human strains in comparison with bovine strains. Nevertheless, this sequence is only present in a few strains (7% of bovine strains and 33% of human strains) and therefore could not represent a host-specific marker. Moreover, three sequences were statistically associated with the pathotype (EHEC or EPEC), but these sequences were not present in more than half of the EPEC strains.